EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development of a pharmacokinetic/pharmacodynamic evaluation model for osteomyelitis and usefulness of tedizolid as an alternative to vancomycin against MRSA osteomyelitis

Xiaoxi Liu, Yuki Enoki iD, Kazuaki Taguchi, Kazuaki Matsumoto

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgae124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Xiaoxi Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1-5-30 Shiba koen, Minato-ku, Tokyo 105-8512, Japan. Hauptthemen laut MEDLINE: Osteomyelitis, Vancomycin, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to develop a suitable osteomyelitis model for pharmacokinetic/pharmacodynamic (PK/PD) evaluation and to investigate the target PK/PD values of vancomycin and tedizolid against methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis.

Methods

An osteomyelitis model was established by implanting an MRSA-exposed sterilized suture in the tibia of normal mice and mice with cyclophosphamide-induced neutropenia. The suitability of the osteomyelitis mouse model for PK/PD evaluation was assessed using vancomycin as an indicator. The target PK/PD values for tedizolid were determined using this model. Key findings In neutropenic mice, to achieve a static effect and 1 log10 kill against MRSA, the ratios of the area under the free drug concentration–time curve for 24 h to the minimum inhibitory concentration (fAUC24/MIC) of vancomycin were 91.29 and 430.03, respectively, confirming the validity of the osteomyelitis model for PK/PD evaluation. In immunocompetent mice, the target fAUC24/MIC values of tedizolid for achieving a static effect and 1 log10 kill against MRSA were 2.40 and 49.20, respectively. Additionally, only a 0.28 log10 kill was achieved in neutropenic mice with 20 times the human equivalent dose of tedizolid.

Conclusions

In patients with restored immunity, tedizolid can potentially be used as an alternative to intravenous vancomycin therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteomyelitisVancomycinMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsStaphylococcal InfectionsOxazolesOrganophosphatesOxazolidinonesAnimalsMiceMicrobial Sensitivity TestsDisease Models, AnimalFemaleMaleNeutropeniaCyclophosphamideTetrazoles

Stichwörter der Autor:innen

methicillin-resistant Staphylococcus aureusosteomyelitispharmacokinetics/pharmacodynamicstedizolidvancomycin

Substanzen

VancomycinAnti-Bacterial AgentstedizolidOxazolesOrganophosphatesOxazolidinonesCyclophosphamideTetrazoles

Autor:innen und Institutionen

  • Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1-5-30 Shiba koen, Minato-ku, Tokyo 105-8512, Japan.

ORCID-Profile: Yuki Enoki

Zitieren

APA

Liu, X., Enoki, Y., Taguchi, K., & Matsumoto, K. (2025). Development of a pharmacokinetic/pharmacodynamic evaluation model for osteomyelitis and usefulness of tedizolid as an alternative to vancomycin against MRSA osteomyelitis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae124

Vancouver

Liu X, Enoki Y, Taguchi K, Matsumoto K. Development of a pharmacokinetic/pharmacodynamic evaluation model for osteomyelitis and usefulness of tedizolid as an alternative to vancomycin against MRSA osteomyelitis. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae124

BibTeX
@article{Liu2025,
  author = {Liu, Xiaoxi and Enoki, Yuki and Taguchi, Kazuaki and Matsumoto, Kazuaki},
  title = {Development of a pharmacokinetic/pharmacodynamic evaluation model for osteomyelitis and usefulness of tedizolid as an alternative to vancomycin against MRSA osteomyelitis},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgae124}
}
Kostenlos starten →